Vito Luigi Colona

Dr. Vito Luigi Colona


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2020 in HLA
Verified
Journal Article
Closed access
PDF file
ANAntonio Novelli
Antonio Novelli
MAMarco Andreani
Marco Andreani
MBMichela Biancolella
Michela Biancolella
LLLaura Liberatoscioli
Laura Liberatoscioli
CPChiara Passarelli
Chiara Passarelli
FLFranco Locatelli
Franco Locatelli

26 February 2019 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
TSTommaso Schirinzi
Tommaso Schirinzi
Giuseppina MartellaGiuseppina Martella
Giuseppina Martella
Paola ImbrianiPaola Imbriani
Paola Imbriani
GLGiulia Di Lazzaro
Giulia Di Lazzaro
DFDonatella Franco
Donatella Franco
Antonio PisaniAntonio Pisani
Antonio Pisani
Effective disease-modifying treatments are an urgent need for Parkinson's disease (PD). A putative successful strategy is to counteract oxidative stress, not only with synthetic compounds, but also with natural agents or dietary choices. Vitamin E, in particular, is a powerful antioxidant, commonly found in vegetables and other components of the diet. In this work, we performed a questionnaire based case-control study on 100 PD patients and 100 healthy controls. The analysis showed that a higher dietary intake of Vitamin E was inversely associated with PD occurrence independently from age and gender (OR = 1.022; 95% CI = 0.999–1.045; p < 0.05), though unrelated to clinical severity. Then, in order to provide a mechanistic explanation for such observation, we tested the effects of Vitamin E and other alimentary antioxidants in vitro, by utilizing the homozygous PTEN-induced kinase 1 knockout (PINK1−/−) mouse model of PD. PINK1−/− mice exhibit peculiar alterations of synaptic plasticity at corticostriatal synapses, consisting in the loss of both long-term potentiation (LTP) and long-term depression (LTD), in the absence of overt neurodegeneration. Chronic administration of Vitamin E (alpha-tocopherol and the water-soluble analog trolox) fully restored corticostriatal synaptic plasticity in PINK1−/− mice, suggestive of a specific protective action. Vitamin E might indeed compensate PINK1 haploinsufficiency and mitochondrial impairment, reverting some central steps of the pathogenic process. Altogether, both clinical and experimental findings suggest that Vitamin E could be a potential, useful agent for PD patients. These data, although preliminary, may encourage future confirmatory trials.

1 June 2022 in Human Genomics
Verified
Journal Article
Open access
PDF file
Michela BiancolellaMichela Biancolella
Michela Biancolella
VCVito Luigi Colona
Vito Luigi Colona
RMRuty Mehrian-Shai
Ruty Mehrian-Shai
JWJessica Lee Watt
Jessica Lee Watt
LLLucio Luzzatto
Lucio Luzzatto
Juergen ReichardtJuergen Reichardt
Juergen Reichardt
COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years. Here, we review the current state of research into the disease with focus on its history, human genetics and genomics and the transition from the pandemic to the endemic phase. We are particularly concerned by the lack of solid information from the initial phases of the pandemic that highlighted the necessity for better preparation to face similar future threats. On the other hand, we are gratified by the progress into human genetic susceptibility investigations and we believe now is the time to explore the transition from the pandemic to the endemic phase. The latter will require worldwide vigilance and cooperation, especially in emerging countries. In the transition to the endemic phase, vaccination rates have lagged and developed countries should assist, as warranted, in bolstering vaccination rates worldwide. We also discuss the current status of vaccines and the outlook for COVID-19.

4 November 2019 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
SPSara Petrillo
Sara Petrillo
TSTommaso Schirinzi
Tommaso Schirinzi
GLGiulia Di Lazzaro
Giulia Di Lazzaro
JDJessica D'AMico
Jessica D'AMico
VCVito Luigi Colona
Vito Luigi Colona
Antonio PisaniAntonio Pisani
Antonio Pisani

1 June 2020 in Neurobiology of Aging
Verified
Journal Article
Closed access
TSTommaso Schirinzi
Tommaso Schirinzi
GLGiulia Di Lazzaro
Giulia Di Lazzaro
GSGiulia Maria Sancesario
Giulia Maria Sancesario
SSSusanna Summa
Susanna Summa
SPSimona Petrucci
Simona Petrucci
Antonio PisaniAntonio Pisani
Antonio Pisani

11 September 2020 in Human Genomics
Verified
Journal Article
Open access
PDF file
ANAntonio Novelli
Antonio Novelli
MBMichela Biancolella
Michela Biancolella
PBPaola Borgiani
Paola Borgiani
DCDario Cocciadiferro
Dario Cocciadiferro
VCVito Luigi Colona
Vito Luigi Colona
Giuseppe NovelliGiuseppe Novelli
Giuseppe Novelli
Background: Coronaviruses (CoV) are a large family of viruses that are common in humans and many animal species. Animal coronaviruses rarely infect humans with the exceptions of the Middle East respiratory syndrome (MERS-CoV), the severe acute respiratory syndrome corona virus (SARS-CoV), and now SARS-CoV-2, which is the cause of the ongoing pandemic of coronavirus disease 2019 (COVID-19). Several studies suggested that genetic variants in the ACE2 gene may influence the host susceptibility or resistance to SARS-CoV-2 infection according to the functional role of ACE2 in human pathophysiology. However, many of these studies have been conducted in silico based on epidemiological and population data. We therefore investigated the occurrence of ACE2 variants in a cohort of 131 Italian unrelated individuals clinically diagnosed with COVID-19 and in an Italian control population, to evaluate a possible allelic association with COVID-19, by direct DNA analysis. Methods: As a pilot study, we analyzed, by whole-exome sequencing, genetic variants of ACE2 gene in 131 DNA samples of COVID-19 patients hospitalized at Tor Vergata University Hospital and at Bambino Gesù Children’s Hospital, Rome. We used a large control group consisting of 1000 individuals (500 males and 500 females). Results: We identified three different germline variants: one intronic c.439+4G>A and two missense c.1888G>C p.(Asp630His) and c.2158A>G p.(Asn720Asp) in a total of 131 patients with a similar frequency in male and female. Thus far, only the c.1888G>C p.(Asp630His) variant shows a statistically different frequency compared to the ethnically matched populations. Therefore, further studies are needed in larger cohorts, since it was found only in one heterozygous COVID-19 patient. Conclusions: Our results suggest that there is no strong evidence, in our cohort, of consistent association of ACE2 variants with COVID-19 severity. We might speculate that rare susceptibility/resistant alleles could be located in the non-coding regions of the ACE2 gene, known to play a role in regulation of the gene activity.